The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 24, 2016

Filed:

Dec. 17, 2010
Applicants:

Jiyoun Lee, Stanford, CA (US);

Fangfang Yin, Stanford, CA (US);

Matthew S. Bogyo, Redwood City, CA (US);

Laura E. Edgington, Stanford, CA (US);

Inventors:

Jiyoun Lee, Stanford, CA (US);

Fangfang Yin, Stanford, CA (US);

Matthew S. Bogyo, Redwood City, CA (US);

Laura E. Edgington, Stanford, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/00 (2006.01); A61M 36/14 (2006.01); A61K 49/00 (2006.01); C07K 5/065 (2006.01); C07K 5/068 (2006.01); C07K 5/078 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0056 (2013.01); A61K 49/0032 (2013.01); A61K 49/0052 (2013.01); C07K 5/06078 (2013.01); C07K 5/06086 (2013.01); C07K 5/06139 (2013.01);
Abstract

Compounds which specifically inhibit legumain, also known as asparaginyl endopeptidase are provided. The compounds have an epoxide or N-Michael acceptor warhead, and have an asparagine side chain attached to a nitrogen atom in the backbone adjacent the warhead. The compounds also preferably comprise a proline residue adjacent the asparagine, and the compound may also contain a third residue and/or a label for cellular or in vivo imaging of active legumain.


Find Patent Forward Citations

Loading…